Hemgenix J Code: J1411

Drug & Product Overview

HCPCS Descriptor Injection, etranacogene dezaparvovec-drlb, per therapeutic dose

HCPCS Added Date April 1, 2023

Manufacturer CSL Behring

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose, Multi-Dose

Dosage Form Kit

About Hemgenix

Hemgenix is a medication aligned to the HCPCS J Code: J1411 for billing, pricing, and reimbursement purposes in the United States. It is a Hematology drug administered via the intravenous route and manufactured by CSL Behring.

Manufacturers, reach out to us to add more information.

NDC Code Information

39 NDC packages are crosswalked to J1411. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	Hemgenix
	Hemgenix
	Hemgenix
	Hemgenix

Login to view 39 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Hemgenix Pricing & Reimbursement

J1411 Private Payer Reimbursement

$8,762.50 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Hemgenix CPT Administration Codes

CPT Code	Description
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

CMS does not include Hemgenix (J1411) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1411. Wastage billing guide →

Hemgenix Medically Unlikely Edits (MUE)

The most billing units of J1411 Medicare will pay for one patient in one day, as published by CMS. 1 unit = per therapeutic dose.

Practitioner Office & Hospital Outpatient

1 unit / day

Same limit in both settings

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Hemgenix Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Hemophilia B

Frequently Asked Questions

Is there an available Hemgenix billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for Hemgenix.

Are there any available Hemgenix patient assistance programs?

Hemgenix patient assistance information can be found through CSL Behring. Visit Here →

Where can I find Hemgenix prescribing information?

Hemgenix prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →

Where can I find Hemgenix side effect information?

Our team has not yet identified a source of side effects information for Hemgenix. Please check back in a few weeks.

Does billing Hemgenix require JZ/JW wastage modifiers?

CMS does not include Hemgenix (J1411) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1411. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.